Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Division of General Surgery, Department of Surgery, Taipei Medical University-Shuang Ho Hospital, Number 291, Zhongzheng Road, Zhonghe District, New Taipei City, 235, Taiwan.
Surg Endosc. 2022 Jan;36(1):461-467. doi: 10.1007/s00464-021-08305-4. Epub 2021 Feb 1.
Routine use of intraoperative cholangiography (IOC) during laparoscopic cholecystectomy (LC) for detecting common bile duct stones remains controversial. The 2016 World Society of Emergency Surgery (WSES) guidelines on acute calculous cholecystitis proposed a risk stratification for choledocholithiasis. Our present study aimed to (1) examine the findings of common bile duct (CBD) stones in patients underwent LC with routine use of IOC, and (2) validate the 2016 WSES risk classes for predicting choledocholithiasis.
All patients had LC with IOC routinely performed from November 2012 to December 2017 were reviewed retrospectively. Patients were classified into high-, intermediate-, and low-risk groups based on the 2016 WSES risk classes with modification.
A total of 990 patients with LC and routine IOC were enrolled. CBD stones were detected in 197 (19.9%) patients. The rate of CBD stone detected in low-, intermediate-, high-risk groups were 0%, 14.2%, and 89.6%, respectively. Predictors as following: evidence of CBD stones on abdominal ultrasound or computed tomography, CBD diameter > 6 mm, total bilirubin > 4 mg/dL, bilirubin level = 1.8-4 mg/dL, abnormal liver biochemical test result other than bilirubin, presence of clinical gallstone pancreatitis had statistical significance between patients with and without CBD stones. Major bile duct injury was found in 4 patients (0.4%). All 4 patients had uneventful recovery after repair surgery.
Based on our study results, the 2016 WSES risk classes for choledocholithiasis could be an effective approach for predicting the risk of choledocholithiasis. Considering its advantages for detecting CBD stones and biliary injuries, the routine use of IOC is still suggested.
在腹腔镜胆囊切除术(LC)中常规使用术中胆管造影术(IOC)来检测胆总管结石仍存在争议。2016 年世界急诊外科学会(WSES)关于急性胆石性胆囊炎的指南提出了胆总管结石的风险分层。本研究旨在:(1)检查常规使用 IOC 的 LC 患者胆总管(CBD)结石的检出情况;(2)验证 2016 年 WSES 风险分级对预测胆总管结石的作用。
回顾性分析 2012 年 11 月至 2017 年 12 月期间所有接受 LC 并常规行 IOC 的患者。根据 2016 年 WSES 风险分级进行改良后,将患者分为高危、中危和低危组。
共纳入 990 例行 LC 并常规行 IOC 的患者。197 例(19.9%)患者检出 CBD 结石。低危、中危、高危组 CBD 结石检出率分别为 0%、14.2%和 89.6%。以下因素为 CBD 结石的预测因素:腹部超声或 CT 提示 CBD 结石、CBD 直径>6mm、总胆红素>4mg/dL、胆红素水平为 1.8-4mg/dL、除胆红素外的肝功能生化检查异常、存在胆源性胰腺炎的临床表现。4 例(0.4%)患者发生主要胆管损伤,经修复手术后均痊愈。
根据本研究结果,2016 年 WSES 胆总管结石风险分级可有效预测胆总管结石的风险。考虑到其在检测 CBD 结石和胆管损伤方面的优势,仍建议常规使用 IOC。